She joined CDER Office of Compliance in 1999 and was instrumental in bridging many cross-cutting CMC review and CGMP issues in drug manufacturing.

• 她于1999年加盟CDER合规部门，并从事了诸多贯穿药物生产的CMC检验及CGMP工作。